The Vienna Cancer and Thrombosis Study found no association between VTE and any soluble inflammatory marker (except for a trend for the association of IL-1β and IL-6 with VTE in pancreatic cancer) [150], although in another study, IL-6 was found to be an independent predictor of VTE in 200 patients with ovarian cancer (HR 8.9) [151]. The gene discussed is IL6; the disease is familial pancreatic carcinoma.